Immunoglobulin free light chain-kappa, a novel biomarker of inflammation and cardiovascular risk, decreases after smoking cessation in association with NT-proBNP

31 August 2024 (14:00 - 14:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Koji Hasegawa

National Hospital Organization Kyoto Medical Centre, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail

The identification, referral and management of patients with cardiac-related distress: a new model to support psychological recovery after a cardiac event

Professor A. Jackson (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Smoking cessation medicines and e-cigarettes in smokers with obesity

Doctor D. Terentes-Printzios (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Fear of recurrence and its association with mental health outcomes after spontaneous coronary artery dissection (SCAD)

Ms S. Clarke (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Score-2 in heavy smokers: are we underestimating the risk?

Doctor D. Cosmi (Perugia, IT)

Abstract Slides Video

Presentation thumbnail

The Cardiovascular Disease Burden Associated with secondhand smoke, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study

Doctor H. Jiang (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Smoking, mental health, and heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET

You may be interested in

Congress Session

Is smoking still a relevant risk factor?

Congress Session

Markers of inflammation and outcomes in patients with acute coronary syndromes

Congress Presentation

Effectiveness of a smoking cessation intervention in a cardiac rehabilitation program after myocardial infarction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources